Public Consultation: Draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP

Page last updated: 2 April 2024

Consultation on the draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme (PBS) and designated vaccines on the National Immunisation Program (NIP) is now open.

This CRIS sets out the fees that will apply for the 2024-25 financial year and provides information on how the Department of Health and Aged Care (the Department) implements cost recovery for:

• Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for medicines seeking to be listed on the PBS; or vaccines to be listed on the NIP.
• Applicant-driven PBS listing and list management activities.

Notable changes to the draft 2024-25 CRIS include:

• Annual review of indexation for PBS/NIP cost recovery fees.
• Additional information about depreciation costs for IT assets attributable to PBS/NIP.

The final CRIS will be published before the fee changes take effect on 1 July 2024.

The Department of Health and Aged Care welcomes your feedback.

Please provide your comments on the content of the draft 2024-25 CRIS via email: pbscostrecovery@health.gov.au.  Consultation closes COB Wednesday 15 May 2024.